December 13, 2024
Award Program Type: Postdoctoral Fellowship Title of Project: Regulation and significance of the extended-closed conformation of the platelet AIIbB3 integrins The Award begins 01/01/2025, and has been approved at the level of funding indicated below: Period 1 Start Date: 01/01/2025, End Date: 12/31/2025, Total: $77,084.00 Period 2 Start Date: 01/01/2026, End Date: 12/31/2026, Total: $79,556.00 …
December 4, 2024
Nigel Key MD presented at Hematology/Oncology Grand Rounds at Weill Cornell Medicine/New York-Presbyterian Hospital on November 26. The title of his talk was 鈥楥omplications of sickle cell trait: from epidemiology to bench studies鈥�
November 20, 2024
Robert Lee, PhD won Best Oral Presentation award at the 19th International Symposium on Blood Substitutes for his talk entitled “Interpretation of platelet signaling defects in Thromboelastography”
November 15, 2024
Yohei Hisada PhD awarded ISTH SSC small grant. The International Society on Thrombosis and Haemostasis (ISTH) is dedicated to transformative scientific discovery and standardized clinical practices, as well as the education of physicians, scientists and allied health professionals, globally. ISTH prioritizes this commitment by providing funding to support and advance innovative projects of the Scientific …
November 6, 2024
Alisa S. Wolberg, PhD presented the 2024 J. Evan Sadler Lectureship at Washington University in St. Louis. Her talk was entitled, 鈥淰enous Thrombosis and Factor XIII: Linking Biochemical Mechanisms to Novel Therapeutic Strategies鈥�
November 6, 2024
Nigel Mackman PhD, John C. Parker Distinguished Professor of Medicine, gives keynote speech at University of Michigan Frankel Cardiovascular Center Symposium. On Monday September 23rd, Nigel Mackman gave his speech, “Mechanisms of Cancer- Associated Thrombosis and Bleeding: Focus on Tissue Factor- Positive Extracellular Vesicles” Read more here
October 31, 2024
November 2024 Newsletter
October 24, 2024
The publication entitled 鈥淟essons Learned from the National Heart, Lung, and Blood Institute COVID-19 Clinical Trials鈥� describes the process, barriers and successes in the rapid implementation of medical interventional clinical trials addressing morbidity and mortality related to the COVID-19 pandemic. Click here to read
September 20, 2024
Raj Kasthuri, MBBS, professor in the 黑料网 Division of Hematology and director of the 黑料网 HHT Center of Excellence, and a team of researchers published their study evaluating the safety and efficacy of pomalidomide for the treatment of Hereditary Hemorrhagic Telangiectasias in the New England Journal of Medicine.聽 Hereditary Hemorrhagic Telangiectasias (HHT) is an inherited …
September 17, 2024
Yohei Hisada, Ph.D. was awarded an R56 from the NIH NHLBI in the amount of $764,817 for a one-year project titled 鈥淢echanisms of Coagulopathy and Bleeding in Acute Promyelocytic Leukemia.鈥� The award will fund studies to evaluate the hemorrhagic phenotype associated with hyperfibrinolysis in acute promyelocytic leukemia (APL), as well as the global changes in …
September 16, 2024
Nigel Key, MD was an invited plenary speaker at the French Congress on Hemostasis 2024 on September 12 in Lille, France. The title of his lecture was 鈥淚s tranexamic acid a universal hemostatic agent? What is left to learn about mechanism, dosing, timing, risks?鈥� Website: https://www.congres-hemostase.com/
September 10, 2024
Abby Kordeliski has had the final version of her paper “4D intravital imaging studies identify platelets as the predominant cellular procoagulant surface in a mouse hemostasis model”聽published in Blood along with the cover image.聽 聽Abby works in the Wolfgang Bergmeier laboratory in Mary Ellen Jones Building, Congratulations Abby! Cover image Link to the article that …